Clinical Trials in New York State

Showing 6261-6280 of 17,167 trials

Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation

NCT04856904

The purpose of this study is to evaluate the safety and efficacy of trifarotene 50 microgram per gram (mcg/g) cream compared to its vehicle on the risk of formation of atrophic acne scars after 24 weeks of treatment in facial acne participants assessed by atrophic acne scars count.

Acne Vulgaris

Galderma R&D121 participantsStarted May 2021

Scottsdale, Arizona, United States • Fort Smith, Arkansas, United States • Santa Monica, California, United States +15 more locations

TERMINATEDPhase 369 miles

A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

NCT04688931

This global, randomized, controlled, open-label Phase 3 study was designed to assess the long-term efficacy and safety of UGN-102 (mitomycin) for intravesical solution with or without (±) transurethral resection of bladder tumors (TURBT) versus TURBT alone for the treatment of patients with low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder

UroGen Pharma Ltd.282 participantsStarted Feb 2021

Tucson, Arizona, United States • Loma Linda, California, United States • Los Angeles, California, United States +136 more locations

Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation

A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Find Trials by Condition in New York State

Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS

House Dust Mite Allergy Trial In Children

Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease

Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Epacadostat and Pembrolizumab in Patients With GIST

Trial for Treatment Refractory Trigeminal Neuralgia

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)

Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye

Category Learning Retention in Adults With and Without Developmental Language Disorder

A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant